
Michael Hite
Co-founder & CEO


A discreet wearable in development to detect signs of opioid overdose and alert people who can help.
Explore ARMband
ARMband is in development and is not yet FDA-approved. It does not administer naloxone.
Feedback from people with lived experience reshaped the original idea. Ayuda moved away from automatic injection to focus on a smaller detection-and-alert wearable.
Meet the people behind it


Explore the design goals, not a promise of established performance.

An upper-arm form shaped around comfort and discretion.

The research program aims to identify changes that can prompt an alert.

Local alarms and configured phone-based contacts are part of the intended design.

Community voices, research questions and professional collaborations all have a place in the next stage.
Find your way to the teamYour preferences are saved on this device.
A discreet wearable in development to detect signs of opioid overdose and alert people who can help.
Explore ARMband
ARMband is in development and is not yet FDA-approved. It does not administer naloxone.
Feedback from people with lived experience reshaped the original idea. Ayuda moved away from automatic injection to focus on a smaller detection-and-alert wearable.
Meet the people behind it


Explore the design goals, not a promise of established performance.

An upper-arm form shaped around comfort and discretion.

The research program aims to identify changes that can prompt an alert.

Local alarms and configured phone-based contacts are part of the intended design.

Community voices, research questions and professional collaborations all have a place in the next stage.
Find your way to the teamDeveloping a wearable that can call attention to possible overdose signs, even when a person cannot call for help themselves.

Explore the official product visualizations. These are development designs, not an offer to purchase.
Official development visualization
Official development visualization

The intended local detection and alarm functions do not depend on a nearby phone. Setup and remote calls or texts to designated contacts require a compatible phone connection.
Contact permissions and location sharing are part of the setup described in Ayuda’s FAQ.
Read the manufacturer FAQAyuda’s current product information says the device remains in development and is not yet FDA-approved. Contact the company for current availability.
No. The design changed after community feedback and focuses on detection and alerting rather than automatic injection.
No. The company describes a sensing approach focused on possible overdose signs, not chemical detection of opioids.
Use the company’s current FAQ and contact channels for the latest development information.
Official product informationEmergency medicine, device development and community experience inform a person-first approach to overdose detection and alerting.

Michael Hite and emergency physician Dr. Desislava Hite founded Ayuda Medical in Seattle. Listening to prospective wearers helped the team refocus the device on detection and alerting.
Read the official company story
Co-founder & CEO

Co-founder, CMO & Principal Investigator

Expert Advisor

IoT Product Developer

Product Management Advisor

Sr. Firmware Engineer

The company’s development work is supported by NIH and NIDA grant funding. Community engagement remains part of its approach.
Explore ways to get involvedConnect with Ayuda about community participation, research or professional collaboration.
Open the official contact form
No medical information is collected by this concept.
Ask the team about community involvement and current opportunities.
Email the Ayuda teamStudy opportunities and eligibility must be confirmed directly with the company. This site does not enroll participants.
Use the official contact formBring a professional question or partnership idea to the published company mailbox.
Email about partneringThese are education resources, not emergency services. ARMband is in development and should not be relied on as an available emergency-response product.
Independent concept by The SEOFlow Agency. Brand assets, photography and product illustrations originate from the client’s official website. No AI-generated imagery is included. Product visualizations are labelled, not presented as photographs.
Plus Jakarta Sans + DM Sans. Exactly two font families, hosted locally under the SIL Open Font License. License files are included in the ZIP.
Enquiries use existing company services. No enquiry is submitted by this concept. Brand, product claims, staff roles and availability should be reviewed by the client before an official launch.
Return to overview